FEMY - Company ID 0001339005
FEMASYS INC trades as FEMY. In its fiscal 2025 annual report the company posted revenue of $2.29M, up 40.8% from the prior year and net income of -$18.63M. This page tracks FEMASYS INC through 312 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 5 fiscal years FEMASYS INC's revenue grew from $1.04M to $2.29M, a compound annual growth rate of 17.2%. Net profit margin compressed from -666.2% to -812.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-13 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-05-08 |
| Annual report to shareholders | ARS | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy statement | DEF 14A | 2026-04-30 |
| Major company event | 8-K | 2026-04-29 |
| Proxy statement | DEF 14A | 2026-04-06 |
The largest companies sharing FEMASYS INC's SEC industry classification (surgical & medical instruments & apparatus).
FEMASYS INC reported revenue of $2.29M for fiscal year 2025, an increase of 40.8% year over year.
In its latest fiscal year FEMASYS INC reported a net loss of $18.63M.